Scout Investments, Inc. Nektar Therapeutics Transaction History

Scout Investments, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 11, 2019	SELL	$30.43 - $56.65 $14.4 Million - $26.9 Million	-474,135 Closed	0 $0
Q3 2018 Oct 15, 2018	BUY	$46.46 - $68.49 $480,768 - $708,734	10,348 Added 2.23%	474,135 $28.9 Million
Q2 2018 Jul 16, 2018	BUY	$46.25 - $104.45 $4.81 Million - $10.9 Million	103,909 Added 28.87%	463,787 $22.6 Million
Q1 2018 May 09, 2018	BUY	$57.4 - $108.44 $20.7 Million - $39 Million	359,878 New	359,878 $38.2 Million

140

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $247M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Scout Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Scout Investments, Inc. with notifications on news.